HPB Surgery / 2010 / Article / Tab 2 / Clinical Study
Cyberknife Stereotactic Body Radiation Therapy for Nonresectable Tumors of the Liver: Preliminary Results Table 2 Tumor response, recurrence of malignancy, and adverse events in patients treated with Stereotactic Body Radiation Therapy for nonresectable liver tumors.
HCC IHC LM Total Subjects 6 3 8 17 Mean of Follow Up (months) 10.0 5.9 6.9 7.8 Tumor Response RECIST Complete (0) Complete (0) Complete (0) Complete (0) Partial (5) Partial (2) Partial (7) Partial (4) Stable (1) Stable (0) Stable (1) Stable (2) Progress (0) Progress (1) Progress (0) Progress (1) Partial Tumor Grade I (0) Grade I (2) Grade I (0) Grade I (2) Response Grade Grade II (3) Grade II (0) Grade II (2) Grade II (5) Grade III (3) Grade III (1) Grade III (6) Grade III (10) Tumor Recurrence Grade 0 (4) Grade 0 (1) Grade 0 (4) Grade 0 (9) Grade 1a (0) Grade 1a (0) Grade 1a (0) Grade 1a (0) Grade 1b (0) Grade 1b (1) Grade 1b (0) Grade 1b (1) Grade 2 (1) Grade 2 (1) Grade 2 (2) Grade 2 (4) Grade 3 (1) Grade 3 (0) Grade 3 (0) Grade 3 (1) Grade 4 (0) Grade 4 (0) Grade 4 (2) Grade 4 (2) Adverse events From SBRT 0 0 0 0 From markers 0 0 2 2 From surgery 0 0 0 0 # Patients Expired 2 3 3 8